FITC Anti-Human CD9 Antibody[HI9a]

The FITC Anti-Human CD9 Antibody [HI9a] is a highly specific and reliable tool designed for the detection and analysis of CD9 expression in human samples. This antibody is conjugated with FITC, a fluorescent dye that allows for easy visualization and quantification of CD9-positive cells using flow cytometry or fluorescence microscopy techniques.

CD9, also known as tetraspanin-29, is a cell surface glycoprotein that plays a crucial role in various cellular processes, including cell adhesion, migration, and signal transduction. It is widely expressed in various cell types, including leukocytes, platelets, and endothelial cells. The aberrant expression of CD9 has been implicated in several pathological conditions, such as cancer metastasis and immune disorders.

The FITC Anti-Human CD9 Antibody [HI9a] exhibits exceptional specificity and sensitivity, ensuring accurate and reproducible results. It has been extensively validated for its performance in various applications, including immunofluorescence staining, flow cytometry analysis, and immunohistochemistry. This antibody recognizes an epitope on the extracellular domain of CD9, allowing for the detection of both surface and intracellular CD9 expression.

With its superior performance and versatility, the FITC Anti-Human CD9 Antibody [HI9a] is an indispensable tool for researchers and clinicians involved in the study of CD9 biology and its implications in disease. Its high-quality formulation and consistent performance make it an ideal choice for reliable and reproducible experimental results.